Company intelligence / Profile preview
Porton Advanced
Cranbury, New Jersey, USAportonadvanced.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Porton Advanced has supported 16 global IND approvals from NMPA, FDA, and Medsafe. Their pipeline includes CAR-T programs with several at IND or NDA stage in China. They provide end-to-end CDMO services for advanced therapies including cell/gene/mRNA therapeutics[2][4]. Five ATMP projects are currently in Phase I/II clinical trials.
- Therapeutic areas
- OncologyHematology
- Modalities
- Cell therapyGene therapymRNA-based drugsPlasmid DNA therapyViral vector-based therapies (Lentivirus, AAV, Adenovirus)Exosome-based therapyNucleic acid therapies (including circRNA, saRNA)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Eureka Therapeutics – T Cell Therapy development collaboration[4]Geneseed Biotech – Strategic partnership on circRNA innovative therapeutics[5]Yinjia Biosciences – Supply of core protein raw materials/testing reagents for QC/evaluation[3]
Beyond the preview
Go deeper on Porton Advanced.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Porton Advanced.